IL17A and cervical carcinoma: In contrast, activation of MMPs via p38/NFκB pathway with inflammatory cytokines like interleukin 17A (IL-17A), is associated with the invasion of cervical cancer cells, making IL-17A another potential prognosis marker of CESC [57].